Cargando…
Highly sensitive measurements of disease progression in rare disorders: Developing and validating a multimodal model of retinal degeneration in Stargardt disease
BACKGROUND: Each inherited retinal disorder is rare, but together, they affect millions of people worldwide. No treatment is currently available for these blinding diseases, but promising new options—including gene therapy—are emerging. Arguably, the most prevalent retinal dystrophy is Stargardt dis...
Autores principales: | Lambertus, Stanley, Bax, Nathalie M., Fakin, Ana, Groenewoud, Joannes M. M., Klevering, B. Jeroen, Moore, Anthony T., Michaelides, Michel, Webster, Andrew R., van der Wilt, Gert Jan, Hoyng, Carel B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5371327/ https://www.ncbi.nlm.nih.gov/pubmed/28355279 http://dx.doi.org/10.1371/journal.pone.0174020 |
Ejemplares similares
-
Correlation of Morphology and Function of Flecks Using Short-Wave Fundus Autofluorescence and Microperimetry in Patients With Stargardt Disease
por: Dhooge, Patty P. A., et al.
Publicado: (2021) -
Detailed Phenotyping and Therapeutic Strategies for Intronic ABCA4 Variants in Stargardt Disease
por: Khan, Mubeen, et al.
Publicado: (2020) -
The cost-effectiveness of bevacizumab, ranibizumab and aflibercept for the treatment of age-related macular degeneration—A cost-effectiveness analysis from a societal perspective
por: van Asten, Freekje, et al.
Publicado: (2018) -
Association analysis of genetic and environmental risk factors in the cuticular drusen subtype of age-related macular degeneration
por: van de Ven, Johannes P.H., et al.
Publicado: (2012) -
Commentary on “Evidence of complement dysregulation in outer retina of Stargardt disease donor eyes”
por: Dhooge, Patty P.A., et al.
Publicado: (2021)